ARK Shifts Portfolio: Buys Prime Medicine, Sells Absci Shares

nl.investing.com (Dutch) —

Cathie Wood's ARK ETFs made major trades on November 11, 2026, buying 1.74 million Prime Medicine shares worth $6.8 million while selling 478,402 Absci Corp shares valued at $4.77 million. ARK also increased its Archer Aviation stake with 348,176 shares across three funds, reduced BYD holdings by 220,351 shares, and purchased Kratos Defense shares worth $3.13 million. Smaller buys included Rocket Lab and Scribe Therapeutics. The trades reflect ARK's shift toward biotech and aviation while divesting from other sectors. Additional sales included Honeywell Aerospace and Teradyne shares, continuing recent patterns of portfolio rebalancing.


With a significance score of 2.1, this news ranks in the top 22% of today's 31735 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: